<DOC>
	<DOCNO>NCT00684567</DOCNO>
	<brief_summary>The purpose study evaluate safety combination therapy radiotherapy temozolomide ( `` concomitant radiotherapy phase '' ) , temozolomide monotherapy ( `` monotherapy phase '' ) , patient newly diagnose glioblastoma multiforme . Progression free survival response rate also calculate .</brief_summary>
	<brief_title>Temozolomide Phase II Clinical Study Patients With Newly Diagnosed Glioblastoma Multiforme ( Study P04661 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Histopathologically confirm newly diagnose glioblastoma multiforme WHO grade IV . Histological diagnosis must make locally biopsy neurosurgical tumor resection . Four unstained tissue section paraffin block must provide Pathological Judgment Committee tissue specimen . Initial surgery/biopsy diagnosis perform &lt; =6 week ( 42 day ) prior treatment temozolomide . Age : &gt; =18 &lt; =70 year . ECOG performance status &lt; =2 . Stable , nonincreasing dose corticosteroid 14 day prior treatment temozolomide . No prior chemotherapy radiotherapy . Laboratory test value obtain within 14 day initiation administration temozolomide must satisfy follow criterion : absolute neutrophil count &gt; = 1500/mm^3 ; platelet count &gt; = 100,000/mm^3 ; serum creatinine &lt; =1.5 time upper limit laboratory normal ; total bilirubin &lt; =1.5 time upper limit laboratory normal ; glutamic oxaloacetic transaminase glutamic pyruvic transaminase &lt; 2.5 time upper limit laboratory normal ; alkaline phosphatase &lt; 2.5 time upper limit laboratory normal . Absence pathological condition interfere take oral drug . Contraception study period ( informed consent day last observation/examination study ) require sexually active , potentially fertile patient , regardless sex , supervision investigator subinvestigator . The investigator and/or subinvestigator must judge life expectancy 12 week . Patients may include regardless sex inpatient/outpatient . Extensively disseminated glioblastoma multiforme . Severe disorder heart , liver , kidney , blood , etc . Presence previous concurrent malignancy sit exception surgically cure carcinoma insitu cervix non melanoma skin cancer . Women pregnant lactating . Women may pregnant could become pregnant adopt contraception method ( ) . Participation another clinical study within 6 week prior initiation administration temozolomide . Subjects investigator and/or subinvestigator judge inappropriate participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>